documents

Grail Shares Surge as FDA Documents Signal Potential Path Toward Approval for Multi-Cancer Early Detection Test

Shares of Grail, the pioneer in multi-cancer early detection (MCED) technology, climbed 33% on Monday following the release of briefing…